Pharyngeal Squamous Cell Carcinoma — Trials

Pharyngeal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 106
Recruiting: 52
Ph III recruiting: 3
Growth YoY: −15%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05172245	Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer	recruiting	Phase 1	46	National Cancer Institute (NCI)NIH	2	Sep 22, 2026	clinicaltrials
NCT07565740	Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC	recruiting	Phase 1	9	West China HospitalOTHER	1	Sep 22, 2026	clinicaltrials